Cargando…

USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013

In the United States, methicillin-resistant Staphylococcus aureus (MRSA) with the USA300 pulsed-field gel electrophoresis type causes most community-associated MRSA infections and is an increasingly common cause of health care–associated MRSA infections. USA300 probably emerged during the early 1990...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrel, Margaret, Perencevich, Eli N., David, Michael Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622244/
https://www.ncbi.nlm.nih.gov/pubmed/26484389
http://dx.doi.org/10.3201/eid2111.150452
_version_ 1782397565964124160
author Carrel, Margaret
Perencevich, Eli N.
David, Michael Z.
author_facet Carrel, Margaret
Perencevich, Eli N.
David, Michael Z.
author_sort Carrel, Margaret
collection PubMed
description In the United States, methicillin-resistant Staphylococcus aureus (MRSA) with the USA300 pulsed-field gel electrophoresis type causes most community-associated MRSA infections and is an increasingly common cause of health care–associated MRSA infections. USA300 probably emerged during the early 1990s. To assess the spatiotemporal diffusion of USA300 MRSA and USA100 MRSA throughout the United States, we systematically reviewed 354 articles for data on 33,543 isolates, of which 8,092 were classified as USA300 and 2,595 as USA100. Using the biomedical literature as a proxy for USA300 prevalence among genotyped MRSA samples, we found that USA300 was isolated during 2000 in several states, including California, Texas, and midwestern states. The geographic mean center of USA300 MRSA then shifted eastward from 2000 to 2013. Analyzing genotyping studies enabled us to track the emergence of a new, successful MRSA type in space and time across the country.
format Online
Article
Text
id pubmed-4622244
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-46222442015-11-02 USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013 Carrel, Margaret Perencevich, Eli N. David, Michael Z. Emerg Infect Dis Research In the United States, methicillin-resistant Staphylococcus aureus (MRSA) with the USA300 pulsed-field gel electrophoresis type causes most community-associated MRSA infections and is an increasingly common cause of health care–associated MRSA infections. USA300 probably emerged during the early 1990s. To assess the spatiotemporal diffusion of USA300 MRSA and USA100 MRSA throughout the United States, we systematically reviewed 354 articles for data on 33,543 isolates, of which 8,092 were classified as USA300 and 2,595 as USA100. Using the biomedical literature as a proxy for USA300 prevalence among genotyped MRSA samples, we found that USA300 was isolated during 2000 in several states, including California, Texas, and midwestern states. The geographic mean center of USA300 MRSA then shifted eastward from 2000 to 2013. Analyzing genotyping studies enabled us to track the emergence of a new, successful MRSA type in space and time across the country. Centers for Disease Control and Prevention 2015-11 /pmc/articles/PMC4622244/ /pubmed/26484389 http://dx.doi.org/10.3201/eid2111.150452 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Carrel, Margaret
Perencevich, Eli N.
David, Michael Z.
USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
title USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
title_full USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
title_fullStr USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
title_full_unstemmed USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
title_short USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
title_sort usa300 methicillin-resistant staphylococcus aureus, united states, 2000–2013
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622244/
https://www.ncbi.nlm.nih.gov/pubmed/26484389
http://dx.doi.org/10.3201/eid2111.150452
work_keys_str_mv AT carrelmargaret usa300methicillinresistantstaphylococcusaureusunitedstates20002013
AT perencevichelin usa300methicillinresistantstaphylococcusaureusunitedstates20002013
AT davidmichaelz usa300methicillinresistantstaphylococcusaureusunitedstates20002013